TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.52 / 10
Netural
Assessment of technical metrics shows challenging technical structure scoring 3.52/10. Constructive patterns in Long Lower Shadow contrast with challenging signals from MACD Death Cross, Long Upper Shadow, and Marubozu White. Technical assessment: cautious.
Analysis Checks(1/4)
Long Lower Shadow
Score9/10
Win Rate73.33%
Hist. Signals30
Avg Return3.66%
Score9/10
Win Rate73.33%
Hist. Signals30
Avg Return3.66%
MACD Death Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.59%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.59%
Long Upper Shadow
Score2.07/10
Win Rate44.19%
Hist. Signals43
Avg Return-0.11%
Score2.07/10
Win Rate44.19%
Hist. Signals43
Avg Return-0.11%
Marubozu White
Score2.03/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.87%
Score2.03/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.87%
Long Lower Shadow
Score9/10
Win Rate73.33%
Hist. Signals30
Avg Return3.66%
Score9/10
Win Rate73.33%
Hist. Signals30
Avg Return3.66%
Long Upper Shadow
Score2.07/10
Win Rate44.19%
Hist. Signals43
Avg Return-0.11%
Score2.07/10
Win Rate44.19%
Hist. Signals43
Avg Return-0.11%
MACD Death Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.59%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-2.59%
Marubozu White
Score2.03/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.87%
Score2.03/10
Win Rate42.86%
Hist. Signals14
Avg Return-0.87%
What is the current technical signals for TRDA?
- TRDA presents a Netural setup with a Technical Score of 3.52/10. Key technical indicators highlight an RSI of 47.46 and a MACD of -0.24, with the trend anchored by the 50-Day SMA at 10.69. Traders should monitor key support at 9.61 and resistance at 10.72.
